Hiroomi Tada
Hoofd Techniek/Wetenschap/O&O bij TYRA BIOSCIENCES, INC.
Vermogen: 1 M $ op 30-04-2024
Profiel
Mr. Hiroomi Tada is a Chief Medical Officer at Tyra Biosciences, Inc. Mr. Tada was previously employed as an Executive Director by IQVIA, Inc., a Chief Medical Officer by Notable Labs, Inc., a Vice President-Translational Sciences by Target Therapeutics, Inc., an Assistant Professor by Temple University School of Medicine, and an Assistant Professor by UMass Chan Medical School.
He received his undergraduate degree from Haverford College, a doctorate degree from Sidney Kimmel Medical College and a doctorate degree from Thomas Jefferson University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
TYRA BIOSCIENCE, INC
0.16% | 26-03-2024 | 86 435 ( 0.16% ) | 1 M $ | 30-04-2024 |
Actieve functies van Hiroomi Tada
Bedrijven | Functie | Begin |
---|---|---|
TYRA BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 01-11-2020 |
Eerdere bekende functies van Hiroomi Tada
Bedrijven | Functie | Einde |
---|---|---|
Notable Labs, Inc.
Notable Labs, Inc. Hospital/Nursing ManagementHealth Services Notable Labs, Inc. provides personalized testing services for cancer patients. Its testing prioritizes combinations of FDA-approved treatments that can be prescribed by a doctor without a clinical trial. The company was founded by Peter Quinzio and Matthew De Silva in 2013 and is headquartered in Foster City, CA. | Hoofd Techniek/Wetenschap/O&O | - |
Temple University School of Medicine | Corporate Officer/Principal | - |
IMS HEALTH, INC. | Directeur/Bestuurslid | - |
UMass Chan Medical School | Corporate Officer/Principal | - |
Target Therapeutics, Inc.
Target Therapeutics, Inc. Medical SpecialtiesHealth Technology Target Therapeutics, Inc. develops, manufactures and markets disposable and implantable medical devices. It provides medical devices used in minimally invasive procedures to treat vascular diseases and other diseases related to small vessels of the circulatory system. The company was founded by Anna Marie and John R. Daniels in 1985 and is headquartered in Fremont, CA. | Corporate Officer/Principal | - |
Opleiding van Hiroomi Tada
Thomas Jefferson University | Doctorate Degree |
Haverford College | Undergraduate Degree |
Sidney Kimmel Medical College | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
TYRA BIOSCIENCES, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Target Therapeutics, Inc.
Target Therapeutics, Inc. Medical SpecialtiesHealth Technology Target Therapeutics, Inc. develops, manufactures and markets disposable and implantable medical devices. It provides medical devices used in minimally invasive procedures to treat vascular diseases and other diseases related to small vessels of the circulatory system. The company was founded by Anna Marie and John R. Daniels in 1985 and is headquartered in Fremont, CA. | Health Technology |
IQVIA, Inc.
IQVIA, Inc. Data Processing ServicesTechnology Services IQVIA, Inc. provides information technology solutions to the healthcare industry. It offers research and development, enterprise information management, commercial analytics, market analysis, patient consent system, content management, and other related solutions. The company was founded by Bill Frohlich and David Dubow in 1954 and is headquartered in Danbury, CT. | Technology Services |
Notable Labs, Inc.
Notable Labs, Inc. Hospital/Nursing ManagementHealth Services Notable Labs, Inc. provides personalized testing services for cancer patients. Its testing prioritizes combinations of FDA-approved treatments that can be prescribed by a doctor without a clinical trial. The company was founded by Peter Quinzio and Matthew De Silva in 2013 and is headquartered in Foster City, CA. | Health Services |